BRIEF-Eli Lilly and CO incoming CEO David Ricks on CNBC - Amyloid Hypothesis should be continued to be studied in reference to its Alzheimer's drug

* Eli Lilly and CO incoming CEO David Ricks on CNBC -

Amyloid Hypothesis should be continued to be studied in

reference to its Alzheimer's drug

Read more